Clinical Practice: Diagnosis and Evaluation of Dyspepsia
- 1 March 2010
- journal article
- review article
- Published by Wolters Kluwer Health in Journal of Clinical Gastroenterology
- Vol. 44 (3) , 167-172
Abstract
The main issue regarding the approach to the patient with uninvestigated dyspepsia is whether the symptoms are the result of an important clinical illness, which then determines the appropriate management strategy for the treatment of the symptoms. An initial trial of empiric antisecretory drugs is recommended for those without Helicobacter pylori infection and no alarm symptoms, whereas H. pylori eradication is recommended for those with an active H. pylori infection. Treatment expectations for H. pylori infections should theoretically be similar to other common infectious diseases. In most regions, clarithromycin resistance has undermined traditional triple therapy so that it is no longer a suitable choice as an empiric therapy. Four drug therapies, such as sequential, concomitant, and bismuth-quadruple therapy are generally still acceptable choices as empiric therapies. Posteradication testing is highly recommended to provide early identification of otherwise unrecognized increasing antimicrobial resistance. However, despite the ability to successfully cure H. pylori infections, a symptomatic response can be expected in only a minority of those with dyspepsia not associated with ulcers (so called nonulcer dyspepsia ). Overall, from the patients stand point, symptomatic relief is often difficult to achieve and physicians must rely on reassurance along with empiric and individualized care.Keywords
This publication has 50 references indexed in Scilit:
- Meta‐analysis: Four‐Drug, Three‐Antibiotic, Non‐bismuth‐Containing “Concomitant Therapy” Versus Triple Therapy for Helicobacter pylori EradicationHelicobacter, 2009
- Efficient Identification and Evaluation of Effective Helicobacter pylori TherapiesClinical Gastroenterology and Hepatology, 2009
- New concepts of resistance in the treatment of Helicobacter pylori infectionsNature Clinical Practice Gastroenterology & Hepatology, 2008
- Therapy for Helicobacter pylori Infection Can be ImprovedDrugs, 2008
- American College of Gastroenterology Guideline on the Management of Helicobacter pylori InfectionAmerican Journal of Gastroenterology, 2007
- One- or two-week triple therapy for Helicobacter pylori : questions of efficacy and inclusion of a dual therapy treatment armGut, 2007
- Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus ReportGut, 2007
- Comparison of 1 and 2 weeks of omeprazole, amoxicillin and clarithromycin treatment for Helicobacter pylori eradication: the HYPER StudyGut, 2007
- Appropriateness of indications for diagnostic upper gastrointestinal endoscopy: Association with relevant endoscopic diseaseGastrointestinal Endoscopy, 1995
- Endoscopy, gastric ulcer, and gastric cancerDigestive Diseases and Sciences, 1993